No Data
Bloomage Biotechnology Corporation Limited (688363.SH): China Life Insurance and Chengda collectively shareholding 1.00% of the company's shares.
On November 11, Geruihui: bloomage biotechnology corporation limited (688363.SH) announced that as of November 11, 2024, Guoshou Chengda reduced its holdings of the company's shares by 4,634,782 shares through centralized auction trading, and reduced its holdings of the company's shares by 182,000 shares through bulk trading, totaling a reduction of 4,816,782 shares, accounting for 1.00% of the total shares of the company. After this equity change, Guoshou Chengda holds 29,616,504 shares of the company, accounting for 6.15% of the total shares of the company.
Bloomage BioTechnology's (SHSE:688363) Sluggish Earnings Might Be Just The Beginning Of Its Problems
gtja: Q3 cosmetics retail off-season compared to weakened, Hong Kong stock beauty companies' hold positions increased compared to the previous period.
In the third quarter, the cosmetic industry has a relatively scattered landscape, with significant differences in the operating pace of each company against the backdrop of weak overall industry demand.
Huaxi Biotech: Huaxi Biotech\'s 2024 Third Quarter Report
Huaxi Biotech 2024 Third Quarter Report
Bloomage Biotechnology Corporation Limited (688363.SH): The net income for the first three quarters was 0.362 billion yuan, a year-on-year decrease of 29.6%.
Glory Power reported on October 30 that Bloomage Biotechnology Corporation Limited (688363.SH) achieved revenue of 3.875 billion yuan in the first three quarters, a year-on-year decrease of 8.2%; net income attributable to the parent company was 0.362 billion yuan, a year-on-year decrease of 29.6%; non-net profit attributable to the parent company was 0.327 billion yuan, a year-on-year decrease of 24.6%.
Bloomage BioTechnology Corporation Limited's (SHSE:688363) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
No Data
No Data
